Zurich-scoped problems

Where the Zurich-to-US crossing breaks.

Cross-border pain points scoped to Zurich principals, family offices, fiduciaries, and medtech, biotech, industrials, and engineering-commercial firms. The generic catalogue lives at Problems.

Swiss discretion vs US visibility

Swiss understatement carries standing in Paradeplatz and reads as category absence in New York. The register correction the American intermediary needs before the Swiss identity can carry.

Read the problem →

Cantonal brand to US scale

Cantonal-tier standing, Zurich cluster adjacency, and Swiss-federal credentials do not translate to US intermediary due-diligence. What has to be rebuilt for the American peer-set filter.

Read the problem →

Your Zurich-to-US pain not listed?

Describe the US activity, where it stalls, and what you have tried. Response within one business day.

Start the conversation
Start the conversation